These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3564380)

  • 1. [Role of modern diet therapy in the prevention of visceral complications in patients with dietary obesity].
    Kadyrova RKh; Shakieva RA; Salkhanov BA
    Vopr Pitan; 1987; (1):16-20. PubMed ID: 3564380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
    Heyden S
    Nutr Metab; 1978; 22(3):141-59. PubMed ID: 634508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of sustained moderate weight loss in obesity.
    Pasanisi F; Contaldo F; de Simone G; Mancini M
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):401-6. PubMed ID: 12055705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical complications of obesity.
    Angel A; Roncari DA
    Can Med Assoc J; 1978 Dec; 119(12):1408-11. PubMed ID: 737618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has knowledge of atherosclerosis advanced sufficiently to warrant its application to a practical prevention program? The 1970 G. Lyman Duff Memorial Lecture, Council on Arteriosclerosis, American Heart Association.
    Katz LN
    Circulation; 1972 May; 45(5):8-20. PubMed ID: 5020805
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a reducing diet on metabolic disorders in ischemic heart disease patients having excess weight].
    Samsonov MA; Frolova IA; Paramonova EG; Meshcheriakova VA; Zubenko AD
    Vopr Pitan; 1980; (3):16-21. PubMed ID: 7405126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of using dietary factors in the prevention and treatment of ischemic heart disease].
    Meshcheriakova VA; Samsonov MA; Paramonova EG
    Ter Arkh; 1985; 57(10):14-9. PubMed ID: 4081992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excess body weight at a young age as a risk factor for developing metabolic diseases].
    Popova IuP; Fedortsova LP; Sheviakova LV; Beiul YeA
    Vopr Pitan; 1989; (1):13-5. PubMed ID: 2718410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of diet therapy and increased physical activity on risk factors for atherosclerosis in obese patients with ischemic coronary heart disease].
    Omácka A; Dudková R; Baumgartner M
    Sb Lek; 2000; 101(1):121-5. PubMed ID: 10953644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contrast-unloading week in the complex therapy of patients with metabolic-alimentary obesity and its effect on changes in body weight and lipid metabolism indices].
    Loĭko VI; Baketova NN; Lebedeva EA; Kolmakov VN; Skovorodnikova ES
    Vopr Pitan; 1979; (5):30-3. PubMed ID: 516598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in liver function in patients with alimentary obesity combined with cholecystitis as affected by diet therapy].
    Mil'ko VI; Stepanova NV; Moskaleno NI
    Vopr Pitan; 1983; (3):46-9. PubMed ID: 6613072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidermiology and associated risk factors of hyperlipoproteinemia].
    Haller H
    Z Gesamte Inn Med; 1977 Apr; 32(8):124-8. PubMed ID: 883354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
    Jansen PL
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of reducing--revisited.
    Blackburn GL; Read JL
    Postgrad Med J; 1984; 60 Suppl 3():13-8. PubMed ID: 6240029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways.
    Uebanso T; Taketani Y; Fukaya M; Sato K; Takei Y; Sato T; Sawada N; Amo K; Harada N; Arai H; Yamamoto H; Takeda E
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E76-84. PubMed ID: 19435858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.